ovarian cancer
SaudiVarKB evidence summary derived from retained literature mentions.
115Phenotype mentions
100Publications
50Associated gene records
50Associated variant records
Associated gene records
Co-mentioned in the same publications| Gene | Identifier / context | Articles | Mentions |
|---|---|---|---|
| BRCA1 | HGNC:1100 | 23 | 23 |
| BRCA2 | HGNC:1101 | 18 | 18 |
| TP53 | HGNC:11998 | 6 | 6 |
| BRAF | HGNC:1097 | 4 | 4 |
| RAD51D | HGNC:9823 | 3 | 3 |
| PALB2 | HGNC:26144 | 3 | 3 |
| XRCC1 | HGNC:12828 | 3 | 3 |
| PARP1 | HGNC:270 | 2 | 2 |
| CDKN1A | HGNC:1784 | 2 | 2 |
| PTEN | HGNC:9588 | 2 | 2 |
| ABCB1 | HGNC:40 | 2 | 2 |
| LDLR | HGNC:6547 | 2 | 2 |
| RAD51C | HGNC:9820 | 2 | 2 |
| MSH6 | HGNC:7329 | 2 | 2 |
| FANCI | HGNC:25568 | 2 | 2 |
| PIK3CA | HGNC:8975 | 2 | 2 |
| CD44 | HGNC:1681 | 2 | 2 |
| FANCD2 | HGNC:3585 | 2 | 2 |
| BUB1 | HGNC:1148 | 2 | 2 |
| BUB1B | HGNC:1149 | 2 | 2 |
| UBE2C | HGNC:15937 | 2 | 2 |
| BARD1 | HGNC:952 | 2 | 2 |
| SIRT1 | HGNC:14929 | 1 | 1 |
| PAH | HGNC:8582 | 1 | 1 |
| PTTG1 | HGNC:9690 | 1 | 1 |
| TNFRSF10D | HGNC:11907 | 1 | 1 |
| CDK4 | HGNC:1773 | 1 | 1 |
| DNMT3B | HGNC:2979 | 1 | 1 |
| CD40 | HGNC:11919 | 1 | 1 |
| TBX4 | HGNC:11603 | 1 | 1 |
| TG | HGNC:11764 | 1 | 1 |
| SOD1 | HGNC:11179 | 1 | 1 |
| BRD4 | HGNC:13575 | 1 | 1 |
| G6PD | HGNC:4057 | 1 | 1 |
| AGL | HGNC:321 | 1 | 1 |
| PTGS2 | HGNC:9605 | 1 | 1 |
| VEGFA | HGNC:12680 | 1 | 1 |
| KRAS | HGNC:6407 | 1 | 1 |
| ATM | HGNC:795 | 1 | 1 |
| AKT1 | HGNC:391 | 1 | 1 |
| MALAT1 | HGNC:29665 | 1 | 1 |
| LIG1 | HGNC:6598 | 1 | 1 |
| ASPM | HGNC:19048 | 1 | 1 |
| SCN5A | HGNC:10593 | 1 | 1 |
| MLH1 | HGNC:7127 | 1 | 1 |
| MSH2 | HGNC:7325 | 1 | 1 |
| PMS2 | HGNC:9122 | 1 | 1 |
| CYP3A5 | HGNC:2638 | 1 | 1 |
| RAD51 | HGNC:9817 | 1 | 1 |
| ATP8B1 | HGNC:3706 | 1 | 1 |
Associated variant records
Co-mentioned in the same publications| Variant | Identifier / context | Articles | Mentions |
|---|---|---|---|
| c.1813C>T | c.1813C>T | 2 | 2 |
| p.L605F | p.L605F | 2 | 2 |
| c.1140dupG | c.1140dupG | 2 | 2 |
| c.5095C>T | c.5095C>T | 2 | 2 |
| p.W577C | p.W577C | 1 | 1 |
| G894T | G894T | 1 | 1 |
| rs3200401 | rs3200401 | 1 | 1 |
| c.1140dup | c.1140dup | 1 | 1 |
| p.Arg1699Trp | p.Arg1699Trp | 1 | 1 |
| p.Arg1751* | p.Arg1751* | 1 | 1 |
| c.3217_3218del | c.3217_3218del | 1 | 1 |
| p.Gly1073* | p.Gly1073* | 1 | 1 |
| c.5234del | c.5234del | 1 | 1 |
| p.Arg2494* | p.Arg2494* | 1 | 1 |
| c.643del | c.643del | 1 | 1 |
| c.193G>A | c.193G>A | 1 | 1 |
| p.Glu65Leu | p.Glu65Leu | 1 | 1 |
| rs1061540 | rs1061540 | 1 | 1 |
| c.2835-2_2835-1delinsTT | c.2835-2_2835-1delinsTT | 1 | 1 |
| c.3425delT | c.3425delT | 1 | 1 |
| H132P | H132P | 1 | 1 |
| R177C | R177C | 1 | 1 |
| R217C | R217C | 1 | 1 |
| R230C | R230C | 1 | 1 |
| rs1331262028 | rs1331262028 | 1 | 1 |
| c.414G>C | c.414G>C | 1 | 1 |
| p.Leu138Phe | p.Leu138Phe | 1 | 1 |
| c.705G>T | c.705G>T | 1 | 1 |
| p.Lys235Asn | p.Lys235Asn | 1 | 1 |
| c.137C>G | c.137C>G | 1 | 1 |
| p.Ser46Cys | p.Ser46Cys | 1 | 1 |
| c.620C>T | c.620C>T | 1 | 1 |
| p.Ser207Leu | p.Ser207Leu | 1 | 1 |
| c.694C>T | c.694C>T | 1 | 1 |
| p.Arg232Ter | p.Arg232Ter | 1 | 1 |
| c.5407-25T>A | c.5407-25T>A | 1 | 1 |
| c.4136_4137delCT | c.4136_4137delCT | 1 | 1 |
| c.1140dupG | c.1140dupG | 1 | 1 |
| rs28897672 | Rs28897672 | 1 | 1 |
| rs799917 | rs799917 | 1 | 1 |
| rs4986852 | rs4986852 | 1 | 1 |
| c.4136_4137delCT | c.4136_4137delCT | 1 | 1 |
| c.5530delC | c.5530delC | 1 | 1 |
| c.5266dupC | c.5266dupC | 1 | 1 |
| c.68_69delAG | c.68_69delAG | 1 | 1 |
| c.4041_4042delAG | c.4041_4042delAG | 1 | 1 |
| c.1310_1313delAAGA | c.1310_1313delAAGA | 1 | 1 |
| -248G>A | -248G>A | 1 | 1 |
| C1236T | C1236T | 1 | 1 |
| C3435T | C3435T | 1 | 1 |
Associated population records
Co-mentioned in the same publications| Population | Identifier / context | Articles | Mentions |
|---|---|---|---|
| Saudi Arabia | — | 6 | 6 |
| Population record | Cohort 17 | 2 | 2 |
| Population record | Cohort 27 | 2 | 2 |
| Population record | Cohort 10 | 1 | 1 |
| Saudi Arabia | Cohort 88 | 1 | 1 |
| Saudi Arabia · Riyadh | — | 1 | 1 |
| Population record | Cohort 47 | 1 | 1 |
| Saudi Arabia · Jeddah | — | 1 | 1 |
| Population record | Cohort 100 | 1 | 1 |
| Population record | Cohort 28 | 1 | 1 |
| Saudi Arabia | Cohort 5 | 1 | 1 |
| Population record | Cohort 15 | 1 | 1 |
| Population record | Cohort 70 | 1 | 1 |
| Population record | Cohort 94 | 1 | 1 |
| Saudi Arabia · Asir | — | 1 | 1 |
| Population record | Cohort 192 | 1 | 1 |
| Saudi Arabia · Hail | Cohort 1 | 1 | 1 |
| Saudi Arabia · Eastern Province | — | 1 | 1 |
| Saudi Arabia | Cohort 200 | 1 | 1 |
| Population record | Cohort 734 | 1 | 1 |
| Saudi Arabia | Cohort 70 | 1 | 1 |
| Population record | Cohort 195 | 1 | 1 |
| Saudi Arabia | Cohort 209 | 1 | 1 |
| Saudi Arabia | Cohort 240 | 1 | 1 |
| Saudi Arabia | Cohort 908 | 1 | 1 |
| Population record | Cohort 407 | 1 | 1 |
| Saudi Arabia | Cohort 53 | 1 | 1 |
| Population record | Cohort 2,386 | 1 | 1 |
| Saudi Arabia | Cohort 159 | 1 | 1 |
Supporting publications
100 records- 2026CRISPR-Edited Cell Lines: A New Era in Functional Oncology Research.Current pharmaceutical design1 mentions
- 2026Molecular Signature of Cisplatin Resistance in Ovarian Cancer Identifies Therapeutic Opportunities for Re-sensitization.Journal of Cancer1 mentions
- 2026Homologous recombination deficiency in newly diagnosed advanced ovarian cancer across nine Middle East countries: prevalence, real-world testing pathways, and treatment implications.BMC cancer1 mentions
- 2026Advances in Next-Generation Immunotherapies for Ovarian Cancer: Mechanisms of Immune Evasion and Novel Therapeutic Targets.Biomolecules1 mentions
- 2026Brain metastases among patients with gynecologic cancers: a single-centre retrospective study of patients treated with brain radiotherapy.Journal of neuro-oncology1 mentions
- 2026Development of a three-dimensional collagen hydrogel model incorporating laurus nobilis extract-chitosan nanoparticles against ovarian cancer SKOV3 cells.The International journal of artificial organs1 mentions
- 2026Machine learning-based DNA microarray analysis for disease detection using the MICRO-AI framework.Science progress1 mentions
- 2026Exploring the Prognostic, Mutational and Therapeutic Potential of ANXA2 in Ovarian Cancer via Multi-Omics and In Silico Approach.Biology1 mentions
- 2026Advances in PARP Inhibition in Improving Outcomes of Breast Cancer, Ovarian Cancer, and Other Solid Tumors: Journey of Discovery, Development, and Clinical Updates of Talazoparib.Drug design, development and therapy1 mentions
- 2026Molecular Characterization of Ovarian Endometriosis in Saudi Arabian Women: Insights into Inflammatory, Autophagic, and Epigenetic Dysregulation.International journal of molecular sciences1 mentions
- 2026PPAR-γ agonist Inactivate Cellular Senescence by Inhibiting SIRT1 Signaling to Confer Increased Sensitivity to Olaparib in Ovarian Cancer Cells.Saudi journal of medicine & medical sciences1 mentions
- 2026Prevalence of BRCA1 and BRCA2 Germline Mutations in Western Saudi Patients with Epithelial Tubo-Ovarian Carcinoma.Saudi medical journal1 mentions
- 2026Applications of artificial intelligence and machine learning models in the prognosis and diagnosis of ovarian cancer.Frontiers in oncology1 mentions
- 2026Immune Landscape and Tumour Heterogeneity in Ovarian Cancer: Insights From Single-Cell RNA Sequencing.Journal of cellular and molecular medicine1 mentions
- 2025Mitochondrial dysfunction route as a possible biomarker and therapy target for human cancer.Biomedical journal1 mentions
- 2025A Clinicopathological Study of Surface Epithelial Tumors of the Ovary: A Retrospective Analysis at a Tertiary Care Center in Jeddah, Saudi Arabia.Cureus1 mentions
- 2025Unraveling the role of lncRNA in Endometriosis-Associated immune system Dysregulation: Exploring the intricate immunological changes and disrupted signaling pathways.Human immunology1 mentions
- 20253D Microtumors Representing Ovarian Cancer Minimal Residual Disease Respond to the Fatty Acid Oxidation Inhibitor Perhexiline.Advanced healthcare materials1 mentions
- 2025Prevalence of homologous recombination deficiency among women with newly diagnosed ovarian, primary peritoneal, and/or fallopian tube cancer: the international HALO study.International journal of gynecological cancer : official journal of the International Gynecological Cancer Society1 mentions
- 2025The Role of Hypoxia-Inducible Factor-1α (HIF-1α) in the Progression of Ovarian Cancer: Perspectives on Female Infertility.Cells1 mentions
- 2025Integrative In Silico Analysis to Identify Functional and Structural Impacts of nsSNPs on Programmed Cell Death Protein 1 (PD-1) Protein and UTRs: Potential Biomarkers for Cancer Susceptibility.Genes1 mentions
- 2025Reduced occludin expression is related to unfavorable tumor phenotype and poor prognosis in many different tumor types: A tissue microarray study on 16,870 tumors.PloS one1 mentions
- 2025Bisphenol-A-induced ovarian cancer: Changes in epithelial diversity, apoptosis, antioxidant and anti-inflammatory mechanisms.Reproductive toxicology (Elmsford, N.Y.)1 mentions
- 2025Mutational spectrum and profile of breast and ovarian cancer patients in Saudi Arabia's western region: single center experience.Discover oncology1 mentions
- 2025A rare presentation of high-grade serous ovarian carcinoma with ulcerating inguinal lymph node metastasis: a case report.Journal of surgical case reports1 mentions
- 2025Matrix Metalloproteinases 1 and 3 in Ovarian Cancer: Diagnostic and Prognostic Potential of Genetic Variants and Expression Profiling.Diagnostics (Basel, Switzerland)1 mentions
- 2025RAD51 and PALB2 in precision oncology: Clinical implications for HRD associated breast and ovarian cancers (Review).International journal of oncology1 mentions
- 2025A Comprehensive Review on the Molecular Mechanism of Lycopene in Cancer Therapy.Food science & nutrition1 mentions
- 2025In-silico identification and functional analysis of high-risk oncogenic nsSNPs in the human SDHB gene and their implications for cancer susceptibility.3 Biotech1 mentions
- 2025Boosting bioavailability of PROTACs for ovarian cancer: From chemistry to clinical translation.Bioorganic chemistry1 mentions
- 2025P53 Mutation Induces Epithelial-to-Mesenchymal Transition (EMT) Associated with Stem Cell Properties and Tumorigenesis in Fallopian Tube Cells.Cancers1 mentions
- 2025Cellular cAMP Content and Mitochondrial Profile Define Different Subtypes of Ovarian Cancer Cells.International journal of molecular sciences1 mentions
- 2025Identification of key candidate genes for ovarian cancer using integrated statistical and machine learning approaches.Briefings in bioinformatics1 mentions
- 2025Crosstalk between microRNA and oxidative stress in ovarian cancer: diagnosis, pathogenesis and therapeutic resistance.Medical oncology (Northwood, London, England)1 mentions
- 2024Identification of Novel Genes and Pathways of Ovarian Cancer Using a Comprehensive Bioinformatic Framework.Applied biochemistry and biotechnology1 mentions
- 2024Angio-Long Noncoding RNA MALAT1 (rs3200401) and MIAT (rs1061540) Gene Variants in Ovarian Cancer.Epigenomes1 mentions
- 2024Constitutional BRCA1 and MGMT Methylation Are Significant Risk Factors for Triple-Negative Breast Cancer and High-Grade Serous Ovarian Cancer in Saudi Women.International journal of molecular sciences1 mentions
- 2024Unravelling driver genes as potential therapeutic targets in ovarian cancer via integrated bioinformatics approach.Journal of ovarian research1 mentions
- 2024Targeting tumour markers in ovarian cancer treatment.Clinica chimica acta; international journal of clinical chemistry1 mentions
- 2024From desert flora to cancer therapy: systematic exploration of multi-pathway mechanisms using network pharmacology and molecular modeling approaches.Frontiers in pharmacology1 mentions
- 2024The Oncogenic Potential of Human Papillomavirus in Relation to Multiple Types of Cancer in Saudi Arabia: A Systematic Review.Cureus1 mentions
- 2024Enhancing precision targeting of ovarian cancer tumor cells in vivo through extracellular vesicle engineering.International journal of cancer1 mentions
- 2024Stimulator of Interferon Genes Protein (STING) Expression in Cancer Cells: A Tissue Microarray Study Evaluating More than 18,000 Tumors from 139 Different Tumor Entities.Cancers1 mentions
- 2024Bisphenol A-induced oxidative stress increases the production of ovarian cancer stem cells in mice.Reproductive toxicology (Elmsford, N.Y.)1 mentions
- 2024Effect of novel IL-8 gene mutation on its protein structure and stability among ovarian cancer patients in Saudi Arabia.Bioinformation1 mentions
- 2023Pathogenicity of PKCγ Genetic Variants-Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer.Genes1 mentions
- 2023Molecular Genetic Characteristics of FANCI, a Proposed New Ovarian Cancer Predisposing Gene.Genes1 mentions
- 2023The emerging role of MCPH1/BRIT1 in carcinogenesis.Frontiers in oncology1 mentions
- 2023Genetic analyses of DNA repair pathway associated genes implicate new candidate cancer predisposing genes in ancestrally defined ovarian cancer cases.Frontiers in oncology1 mentions
- 2023PALB2 germline mutations in a large cohort of Middle Eastern breast-ovarian cancer patients.Scientific reports1 mentions
- 2023Comprehensively analyzing the genetic alterations, and identifying key genes in ovarian cancer.Oncology research1 mentions
- 2023Identification of novel candidate targets for suppressing ovarian cancer progression through IL-33/ST2 axis components using the system biology approach.Frontiers in molecular biosciences1 mentions
- 2023Challenges and Opportunities in the Crusade of BRAF Inhibitors: From 2002 to 2022.ACS omega1 mentions
- 2023Exploring the multi-gene regulatory molecular mechanism of Saudi Arabian flora against epilepsy based on data mining, network pharmacology and docking analysis.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society1 mentions
- 2023Muir-Torre syndrome and recent updates on screening guidelines: The link between colorectal tumors and sebaceous adenomas in unusual locations.Journal of surgical oncology1 mentions
- 2023Cross talk of tumor protein D52 (TPD52) with KLF9, PKCε, and MicroRNA 223 in ovarian cancer.Journal of ovarian research1 mentions
- 2023Exploring the role of lncrna neat1 knockdown in regulating apoptosis across multiple cancer types: A review.Pathology, research and practice1 mentions
- 2023Targeting Cytochrome P450 Enzymes in Ovarian Cancers: New Approaches to Tumor-Selective Intervention.Biomedicines1 mentions
- 2023Maximal clique centrality and bottleneck genes as novel biomarkers in ovarian cancer.Biotechnology & genetic engineering reviews1 mentions
- 2022Poly(ADP-Ribose) Polymerase-1 Inhibitors Drug Discovery, Design, and Development as Anticancer Agents from Past to Present: A Mini-Review.Mini reviews in medicinal chemistry1 mentions
- 2022Assessing frequency and clinical outcomes of BRCA mutated ovarian cancer in Saudi women.BMC cancer1 mentions
- 2022Low-Grade Serous Carcinoma of the Ovary: The Current Status.Diagnostics (Basel, Switzerland)1 mentions
- 2022Interaction Analysis of MRP1 with Anticancer Drugs Used in Ovarian Cancer: In Silico Approach.Life (Basel, Switzerland)1 mentions
- 2022Case Review: Whole-Exome Sequencing Analyses Identify Carriers of a Known Likely Pathogenic Intronic BRCA1 Variant in Ovarian Cancer Cases Clinically Negative for Pathogenic BRCA1 and BRCA2 Variants.Genes1 mentions
- 2022The Genetic and Molecular Analyses of RAD51C and RAD51D Identifies Rare Variants Implicated in Hereditary Ovarian Cancer from a Genetically Unique Population.Cancers1 mentions
- 2022Enhancement of MDM2 inhibitory effects through blocking nuclear export mechanisms in ovarian cancer cells.Cancer genetics1 mentions
- 2022Targeting Mre11 overcomes platinum resistance and induces synthetic lethality in XRCC1 deficient epithelial ovarian cancers.NPJ precision oncology1 mentions
- 2022Metabolic reprogramming by miRNAs in the tumor microenvironment: Focused on immunometabolism.Frontiers in oncology1 mentions
- 2022The Potential Role of MUC16 (CA125) Biomarker in Lung Cancer: A Magic Biomarker but with Adversity.Diagnostics (Basel, Switzerland)1 mentions
- 2021Screening for PIK3CA mutations among Saudi women with ovarian cancer.Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology1 mentions
- 2021Molecular disruption of DNA polymerase β for platinum sensitisation and synthetic lethality in epithelial ovarian cancers.Oncogene1 mentions
- 2021FEN1 Blockade for Platinum Chemo-Sensitization and Synthetic Lethality in Epithelial Ovarian Cancers.Cancers1 mentions
- 2021Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor-initiating cells.JCI insight1 mentions
- 2021Transporter associated with antigen processing 1 (TAP1) expression and prognostic analysis in breast, lung, liver, and ovarian cancer.Journal of molecular medicine (Berlin, Germany)1 mentions
- 2021The Genetic Analyses of French Canadians of Quebec Facilitate the Characterization of New Cancer Predisposing Genes Implicated in Hereditary Breast and/or Ovarian Cancer Syndrome Families.Cancers1 mentions
- 2021Ligase 1 is a predictor of platinum resistance and its blockade is synthetically lethal in XRCC1 deficient epithelial ovarian cancers.Theranostics1 mentions
- 2021A functionally impaired missense variant identified in French Canadian families implicates FANCI as a candidate ovarian cancer-predisposing gene.Genome medicine1 mentions
- 2021Leptin Protein Expression and Promoter Methylation in Ovarian Cancer: A Strong Prognostic Value with Theranostic Promises.International journal of molecular sciences1 mentions
- 2021Predicting Diagnostic Potential of Cathepsin in Epithelial Ovarian Cancer: A Design Validated by Computational, Biophysical and Electrochemical Data.Biomolecules1 mentions
- 2020Telomerase reverse transcriptase promoter mutations in cancers derived from multiple organ sites among middle eastern population.Genomics1 mentions
- 2020Molecular Evaluation of PROGINS Mutation in Progesterone Receptor Gene and Determination of its Frequency, Distribution Pattern and Association with Breast Cancer Susceptibility in Saudi Arabia.Endocrine, metabolic & immune disorders drug targets1 mentions
- 2020Genetic heterogeneity and evolutionary history of high-grade ovarian carcinoma and matched distant metastases.British journal of cancer1 mentions
- 2020Poly(ADP-ribose) polymerase inhibitors as maintenance treatment in patients with newly diagnosed advanced ovarian cancer: a meta-analysis.Future oncology (London, England)1 mentions
- 2020Design and encapsulation of anticancer dual HSP27 and HER2 inhibitor into low density lipoprotein to target ovarian cancer cells.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society1 mentions
- 2020MDR1 Gene Polymorphisms and Its Association With Expression as a Clinical Relevance in Terms of Response to Chemotherapy and Prognosis in Ovarian Cancer.Frontiers in genetics1 mentions
- 2020Literature Review of BARD1 as a Cancer Predisposing Gene with a Focus on Breast and Ovarian Cancers.Genes1 mentions
- 2020Tissue-based long non-coding RNAs "PVT1, TUG1 and MEG3" signature predicts Cisplatin resistance in ovarian Cancer.Genomics1 mentions
- 2020BRCA1 and BRCA2 genes mutations among high risk breast cancer patients in Jordan.Scientific reports1 mentions
- 2019Genetic epidemiology of ovarian cancer in the 22 Arab countries: A systematic review.Gene1 mentions
- 2019Novel Associations between BRCA1 Variants C.181 T>G (Rs28897672) and Ovarian Crisk in Saudi Females.Journal of medical biochemistry1 mentions
- 2019Prevalence, spectrum, and founder effect of BRCA1 and BRCA2 mutations in epithelial ovarian cancer from the Middle East.Human mutation1 mentions
- 2019Prevalence of BRCA mutations among hereditary breast and/or ovarian cancer patients in Arab countries: systematic review and meta-analysis.BMC cancer1 mentions
- 2019Dual-drug loaded micelle for combinatorial therapy targeting HIF and mTOR signaling pathways for ovarian cancer treatment.Journal of controlled release : official journal of the Controlled Release Society1 mentions
- 2019Development of the Tumor-Specific Antigen-Derived Synthetic Peptides as Potential Candidates for Targeting Breast and Other Possible Human Carcinomas.Molecules (Basel, Switzerland)1 mentions
- 2019miRNA-21 inhibition suppresses the human epithelial ovarian cancer by targeting PTEN signal pathway.Saudi journal of biological sciences1 mentions
- 2018High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients.Breast cancer research and treatment1 mentions
- 2018Main implications related to the switch to BRCA1/2 tumor testing in ovarian cancer patients: a proposal of a consensus.Oncotarget1 mentions
- 2016Potential impact of (rs 4645878) BAX promoter -248G>A and (rs 1042522) TP53 72Arg>pro polymorphisms on epithelial ovarian cancer patients.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico1 mentions
- 2016Human genome meeting 2016 : Houston, TX, USA. 28 February - 2 March 2016.Human genomics1 mentions
- 2016Combinatorial strategies based on CRAd-IL24 and CRAd-ING4 virotherapy with anti-angiogenesis treatment for ovarian cancer.Journal of ovarian research1 mentions